Evidence map›Paper›PMID 22926321›Full record

ReviewAdvanced drug delivery reviews2012

MEMS-enabled implantable drug infusion pumps for laboratory animal research, preclinical, and clinical applications.

Ellis Meng, Tuan Hoang

Open access · greenAbstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Modeling programmable drug delivery in bioelectronics with electrochemical actuation.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Recent advances in bioelectronics chemistry.Chemical Society reviews · 2020
    Review
  9. Review
  10. Battery-free, lightweight, injectable microsystem for in vivo wireless pharmacology and optogenetics.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Prevascularized silicon membranes for the enhancement of transport to implanted medical devices.Journal of biomedical materials research. Part B, Applied biomaterials · 2016
    Article
  17. Microfabrication for Drug Delivery.Materials (Basel, Switzerland) · 2016
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ellis MengDepartment of Biomedical Engineering, University of Southern California, 1042 Downey Way, DRB-140, Los Angeles, CA 90089-1111, USA. ellis.meng@usc.edu
Tuan Hoang
University of Southern California · US

Funding

Microinfusion Pump For Animal Functional Brain MappingR01NS050171 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HOLSCHNEIDER, DANIEL PHILIPP · 2005 to 2007
$1.0M
Implantable MEMS Drug Delivery Device for Glaucoma ManagementR21EY018490 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MENG, ELLIS · 2007 to 2008
$448k
Implantable Minipump For Tetherless Drug Self-Administration In MiceR21DA026970 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HOLSCHNEIDER, DANIEL PHILIPP · 2009 to 2010
$325k
NEI NIH HHS R21 EY018490NEI NIH HHS R21EY018490NIDA NIH HHS R21 DA026970NIDA NIH HHS R21DA026970NINDS NIH HHS R01 NS050171NINDS NIH HHS R01NS050171
6 · The paper itself

Abstract

Innovation in implantable drug delivery devices is needed for novel pharmaceutical compounds such as certain biologics, gene therapy, and other small molecules that are not suitable for administration by oral, topical, or intravenous routes. This invasive dosing scheme seeks to directly bypass physiological barriers presented by the human body, release the appropriate drug amount at the site of treatment, and maintain the drug bioavailability for the required duration of administration to achieve drug efficacy. Advances in microtechnologies have led to novel MEMS-enabled implantable drug infusion pumps with unique performance and feature sets. In vivo demonstration of micropumps for laboratory animal research and preclinical studies include acute rapid radiolabeling, short-term delivery of nanomedicine for cancer treatment, and chronic ocular drug dosing. Investigation of MEMS actuators, valves, and other microstructures for on-demand dosing control may enable next generation implantable pumps with high performance within a miniaturized form factor for clinical applications.

Indexed as

Infusion Pumps, ImplantableMicro-Electrical-Mechanical SystemsAnimal ExperimentationAnimalsAnimals, LaboratoryDrug Evaluation, PreclinicalElectrolysisHumans

Identifiers

PMID22926321
PMCPMC3488150
OpenAlexW2082277811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.